Amendment 378 to article 134, before paragraph 1
Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
A9-0141/2024 – Tiemo Wölken – Article 134, before § 1 – Am 378
Rejected
- For
- 96
- Against
- 450
- Abstained
- 36
roll-call vote at 19:22 · 16% of votes cast in favour
Roll call requested by The Left
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 12 | 0 | 0 | 12 | For |
| Greens | 2 | 23 | 2 | 27 | Against |
| S&D | 7 | 51 | 0 | 58 | Against |
| Renew | 3 | 35 | 0 | 38 | Against |
| EPP | 2 | 73 | 2 | 77 | Against |
| ECR | 0 | 23 | 1 | 24 | Against |
| Patriots | 10 | 12 | 4 | 26 | Divided |
| ESN | 1 | 3 | 0 | 4 | Against |
| No group | 1 | 0 | 3 | 4 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
26 MEPs of 582 Clear filters
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.